Raptor Pharmaceutical Sheds 21% – Reports Wider Q4 Loss Vs. Estimates, Beats on Revenue; Guides FY14 Revenue Below StreetBy Thomas LarsonMarch 14, 2014 Raptor Pharmaceutical (RPTP) continues to trade lower after the company reported late Thursday mixed financial results for Q4 and provided…